CTRI/2015/01/005389
Completed
Phase 4
International Registry to assess mEdical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF) - REPORT-HF
ovartis AG0 sites1,539 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ovartis AG
- Enrollment
- 1539
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients eligible for inclusion in this study have to fulfill all of the following criteria:
- •1\)Patients 18 year old, or older for those countries where the adult age is above 18 year of age, hospitalized at the registry sites with primary diagnosis of acute heart failure. Diagnoses will be made by the treating physicians according to local practices and their clinical judgment (i.e., History/examination; Chest X\-ray; ECG, Echocardiogram, BNP or NT\-proBNP).
Exclusion Criteria
- •Patients eligible for inclusion in this study have to fulfill all of the following criteria:
- •1\. Patients 18 year old, or older for those countries where the adult age is above 18 year of age, hospitalized at the registry sites with primary diagnosis of acute heart failure. Diagnoses will be made by the treating physicians according to local practices and their clinical judgment (i.e., History/examination; Chest X\-ray; ECG, Echocardiogram, BNP or NT\-proBNP).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
International registry for clinical observation and evaluation of extracorporealmembrane oxygenation in critical care and emergency patients (ECMO registry)I46J80R57Cardiac arrestAdult respiratory distress syndromeShock, not elsewhere classifiedDRKS00031584niversitätsklinikum Freiburg100
Not yet recruiting
Not Applicable
An international Multi-Interventional Registry study for chronic ileoAnal pouCh Leaks in UCNL-OMON25472Amsterdam UMC, location AMC1,000
Unknown
Not Applicable
Registry of anti-cancer treatment response prediction tool, CANscript, to understand its use in clinics and impact on the patient treatment outcome.Health Condition 1: null- Solid cancerCTRI/2018/12/016813Mitra RxDx India Pvt Ltd
Not yet recruiting
Phase 3
International clinical research programme to improve outcomes in newly diagnosed Ewing sarcoma – Trial 1ACTRN12624000532505niversity of Birmingham900
Active, not recruiting
Phase 3
International clinical research programme to improve outcomes in newly diagnosed Ewing sarcoma – Trial 1Ewing SarcomaCancerISRCTN17938906niversity of Birmingham900